Viral Safety Copes with Complexity
Viral Clearance Calls for Bioprocess Engineers to Implement Control Strategies
Novel Viral Vectors for Gene Therapy
Synthetic Viral Vectors Show Promise for Mitigating Immune Response to Gene Therapy
Genome-Wide Analysis of the Transcription Start Sites and Promoter Motifs of Phytoplasmas
RNA-Seq of Phytoplasmas Reveals Clues about Transcription Start Sites and Consensus Promoter Sequences
Virus Supply Vexes Gene Therapy Developers, CMOs
Some Contract Manufacturing Organizations Are Ramping Up Capacity in Preparation for a Boom in Viral Vector Demand
Reprints And Permissions
Genetic Engineering & Biotechnology News (GEN) is pleased to announce our partnership with Copyright Clearance Center to meet your licensing needs.
With Copyright Clearance Center's Rightslink® service it's faster and easier than ever before to secure permission from GEN to reuse our content in a book, journal/magazine, newsletter/newspaper, CD-ROM/DVD, brochure/pamphlet, photocopy, coursepack, email, slide kit/presentation or order reprints.
Simply locate your desired content on http://www.genengnews.com/, click the Reprints link in the Keywords and Tools section to open Rightslink.
- Select the way you would like to reuse the content
- Create an account if you haven't already
- Accept the terms and conditions and you're done
For questions about using the Rightslink service, please contact Customer Support via phone 877/622-5543 (toll free) or 978/777-9929, or email [email protected]
If you prefer, please contact us directly:
Reprints & Permissions
Mary Ann Liebert, Inc., publishers
(914) 740-2100 or (800) M-LIEBERT